KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Total Non-Current Liabilities: 2013-2023

Historic Total Non-Current Liabilities for Palvella Therapeutics (PVLA) over the last 5 years, with Dec 2023 value amounting to $10.4 million.

  • Palvella Therapeutics' Total Non-Current Liabilities was N/A to $10.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $10.4 million, marking a year-over-year change of. This contributed to the annual value of $10.4 million for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2023, Palvella Therapeutics' Total Non-Current Liabilities is $10.4 million, which was down 85.92% from $74.0 million recorded in Q4 2020.
  • Palvella Therapeutics' Total Non-Current Liabilities' 5-year high stood at $100.9 million during Q1 2019, with a 5-year trough of $10.4 million in Q4 2023.
  • For the 1-year period, Palvella Therapeutics' Total Non-Current Liabilities averaged around $10.4 million, with its median value being $10.4 million (2023).
  • Data for Palvella Therapeutics' Total Non-Current Liabilities shows a maximum YoY declined of 17.67% (in 2019) over the last 5 years.
  • Palvella Therapeutics' Total Non-Current Liabilities (Quarterly) stood at $84.0 million in 2019, then followed by $74.0 million in 2020, then followed by $10.4 million in 2023.
  • Its Total Non-Current Liabilities stands at $10.4 million for Q4 2023, versus $74.0 million for Q4 2020 and $84.0 million for Q3 2019.